2019 Jul 2;30(1):67-77.e3 4
Pills may also help people mentally move from seeing GLP-1 drugs as treatment, and instead push the drugs into being part of their routine, perhaps helping to remove stigma around taking them
It notes pausing or adjusting the GLP-1 may become necessary, which is a prescriber decision
The litigation continues to evolve as additional plaintiffs file claims involving GLP-1 medications manufactured by Novo Nordisk and Eli Lilly, including Ozempic, Wegovy, Mounjaro, Zepbound, and related drugs
But if the device proves safe and comes with fewer side effects than existing options, some see an opportunity for it to address one of the biggest challenges in obesity treatment: helping patients stay on therapy and maintain their weight loss over time
The peptide, derived from the C-terminal fragment of human growth hormone (amino acids 176-191), targets adipose tissue specifically without the broader metabolic effects associated with full growth hormone therapy
